Failure of 1, 25 dihydroxycholecalciferol (1, 25-(OH) 2-D3) to modify cyclic AMP levels in parathyroid hormone-treated and untreated bone cells

Endocr Res Commun. 1976;3(2):157-66. doi: 10.3109/07435807609052930.

Abstract

Treatment with 1, 25-(OH) 2-D3 (1 ng/ml-25 ng/ml) for periods ranging from 2.5 min. to 60 min. did not alter cyclic AMP levels in bone cells isolated from periosteum-free rat calvaria, or in cells isolated from rat periosteal tissues. 1, 25-(OH) 2-D3 failed to modify the acute increases in cyclic AMP elicited by PTH (10 ng/ml-1 ug/ml). Two separate 1, 25-(OH) 2-D3 preparations, biologically active in other systems, were ineffective under a wide variety of experimental conditions. These results suggest that 1, 25-(OH) 2-D3 is not an acute modulator of cyclic AMP metabolism in PTH-treated and untreated bone cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism*
  • Cells, Cultured
  • Cyclic AMP / metabolism*
  • Dihydroxycholecalciferols / pharmacology*
  • Female
  • Fetus
  • Hydroxycholecalciferols / pharmacology*
  • Parathyroid Hormone / pharmacology*
  • Pregnancy
  • Rats
  • Theophylline / pharmacology

Substances

  • Dihydroxycholecalciferols
  • Hydroxycholecalciferols
  • Parathyroid Hormone
  • Theophylline
  • Cyclic AMP